In the Media: Alzheimer’s Drug Donanemab – What a Promising Trial Means for Treatments

Nature

Dr. Brent P. Forester offers feedback regarding the results of a new Alzheimer’s disease drug trial.

Media Requests

Journalist or member of the media? We are available 24/7 for media requests.